Research Institute for genetic and human therapy
Put Your Health Concerns in the RIGHT Hands
For over 30 years, RIGHT has been funding innovative cutting edge research
RIGHT's research initiated the development of immunologic technologies applicable to both clinical trials and diagnostics
RIGHT has partnered with its commercial spin offs to transfer the discoveries of RIGHT's research to patient therapies
The Coronavirus pandemic (COVID-19) will remain in everyone's mind and heart. We supported a project to quickly identify improved drug combinations for COVID-19, with the goal of supplying safer and more robust treatment to a larger fraction of patients.
We are dedicated to advancing novel therapeutics by providing the latest information on developments and innovations in the field. Through both virtual and in-person networks, we connect researchers, clinicians, patients, policymakers, and advocates to foster collaboration.